This brand name is authorized in Austria, Australia, Spain, Netherlands, Romania, United Kingdom
The drug SEVIKAR HCT contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Olmesartan medoxomil
UNII 6M97XTV3HD - OLMESARTAN MEDOXOMIL
|
|
Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations. |
|
2
Amlodipine
UNII 864V2Q084H - AMLODIPINE BESYLATE
|
|
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
|
3
Hydrochlorothiazide
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
|
|
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C09DX03 | Olmesartan medoxomil, amlodipine and hydrochlorothiazide | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DX Angiotensin II antagonists, other combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10005N, 2836G, 2864R, 2880N, 2953K |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 73450, 73451, 73452, 73453, 73454 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 189865, 189868, 189871, 189874, 189877 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 96407, 96415, 96423, 96431, 96458 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68193001, W68193002, W68193003, W68193004, W68193005, W68193006, W68193007, W68193008, W68193009, W68193010, W68193011, W68193012, W68193013, W68193014, W68193015, W68194001, W68194002, W68194003, W68194004, W68194005, W68194006, W68194007, W68194008, W68194009, W68194010, W68194011, W68194012, W68194013, W68194014, W68194015, W68195001, W68195002, W68195003, W68195004, W68195005, W68195006, W68195007, W68195008, W68195009, W68195010, W68195011, W68195012, W68195013, W68195014, W68195015, W68196001, W68196002, W68196003, W68196004, W68196005, W68196006, W68196007, W68196008, W68196009, W68196010, W68196011, W68196012, W68196013, W68196014, W68196015, W68197001, W68197002, W68197003, W68197004, W68197005, W68197006, W68197007, W68197008, W68197009, W68197010, W68197011, W68197012, W68197013, W68197014, W68197015 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
